{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T22:32:14Z","timestamp":1758925934865},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,4,17]],"date-time":"2014-04-17T00:00:00Z","timestamp":1397692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s00246-014-0906-6","type":"journal-article","created":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T14:20:09Z","timestamp":1397658009000},"page":"1132-1141","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Maternal Medication Use, Fetal 3435 C>T Polymorphism of the ABCB1 Gene, and Risk of Isolated Septal Defects in a Han Chinese Population"],"prefix":"10.1007","volume":"35","author":[{"given":"Chuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoyi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimin","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,17]]},"reference":[{"key":"906_CR1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/oem.2008.042184","volume":"66","author":"MM Brouwers","year":"2009","unstructured":"Brouwers MM, van Tongeren M, Hirst AA, Bretveld RW, Roeleveld N (2009) Occupational exposure to potential endocrine disruptors: further development of a job exposure matrix. Occup Environ Med 66:607\u2013614","journal-title":"Occup Environ Med"},{"key":"906_CR2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.reprotox.2006.01.007","volume":"22","author":"M Ceckova-Novotna","year":"2006","unstructured":"Ceckova-Novotna M, Pavek P, Staud F (2006) P-glycoprotein in the placenta: expression, localization, regulation and function. Reprod Toxicol 22:400\u2013410","journal-title":"Reprod Toxicol"},{"key":"906_CR3","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2174\/156802610792928022","volume":"10","author":"NA Colabufo","year":"2010","unstructured":"Colabufo NA, Berardi F, Perrone MG, Capparelli E, Cantore M, Inglese C, Perrone R (2010) Substrates, inhibitors, and activators of P-glycoprotein: candidates for radiolabeling and imaging perspectives. Curr Top Med Chem 10:1703\u20131714","journal-title":"Curr Top Med Chem"},{"key":"906_CR4","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.amjcard.2011.07.022","volume":"108","author":"M Cresci","year":"2011","unstructured":"Cresci M, Foffa I, Ait-Ali L, Pulignani S, Gianicolo EA, Botto N, Picano E, Andreassi MG (2011) Maternal and paternal environmental risk factors, metabolizing GSTM1 and GSTT1 polymorphisms, and congenital heart disease. Am J Cardiol 108:1625\u20131631","journal-title":"Am J Cardiol"},{"key":"906_CR5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00246-012-0436-z","volume":"34","author":"M Cresci","year":"2013","unstructured":"Cresci M, Foffa I, Ait-Ali L, Pulignani S, Kemeny A, Gianicolo EA, Andreassi MG (2013) Maternal environmental exposure, infant GSTP1 polymorphism, and risk of isolated congenital heart disease. Pediatr Cardiol 34:281\u2013285","journal-title":"Pediatr Cardiol"},{"key":"906_CR6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/EDE.0b013e3181c2979b","volume":"21","author":"H Dolk","year":"2010","unstructured":"Dolk H, Loane MA, Abramsky L, de Walle H, Garne E (2010) Birth prevalence of congenital heart disease. Epidemiology 21:275\u2013277 author reply 277","journal-title":"Epidemiology"},{"key":"906_CR7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.brainres.2011.03.028","volume":"1391","author":"L Dong","year":"2011","unstructured":"Dong L, Luo R, Tong Y, Cai X, Mao M, Yu D (2011) Lack of association between ABCB1 gene polymorphisms and pharmacoresistant epilepsy: an analysis in a western Chinese pediatric population. Brain Res 1391:114\u2013124","journal-title":"Brain Res"},{"key":"906_CR8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tips.2004.06.002","volume":"25","author":"MF Fromm","year":"2004","unstructured":"Fromm MF (2004) Importance of P-glycoprotein at blood\u2013tissue barriers. Trends Pharmacol Sci 25:423\u2013429","journal-title":"Trends Pharmacol Sci"},{"key":"906_CR9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/oxfordjournals.aje.a009876","volume":"149","author":"M Garcia-Closas","year":"1999","unstructured":"Garcia-Closas M, Lubin JH (1999) Power and sample size calculations in case\u2013control studies of gene\u2013environment interactions: comments on different approaches. Am J Epidemiol 149:689\u2013692","journal-title":"Am J Epidemiol"},{"key":"906_CR10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.placenta.2005.09.001","volume":"27","author":"C Gedeon","year":"2006","unstructured":"Gedeon C, Koren G (2006) Designing pregnancy centered medications: drugs which do not cross the human placenta. Placenta 27:861\u2013868","journal-title":"Placenta"},{"key":"906_CR11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.placenta.2004.05.013","volume":"26","author":"S Gil","year":"2005","unstructured":"Gil S, Saura R, Forestier F, Farinotti R (2005) P-glycoprotein expression of the human placenta during pregnancy. Placenta 26:268\u2013270","journal-title":"Placenta"},{"key":"906_CR12","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.7314\/APJCP.2013.14.5.2937","volume":"14","author":"XD Gong","year":"2013","unstructured":"Gong XD, Wang JY, Liu F, Yuan HH, Zhang WY, Guo YH, Jiang B (2013) Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain. Asian Pac J Cancer Prev 14:2937\u20132943","journal-title":"Asian Pac J Cancer Prev"},{"key":"906_CR13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1684\/epd.2011.0419","volume":"13","author":"BS Haerian","year":"2011","unstructured":"Haerian BS, Lim KS, Tan HJ, Mohamed EH, Tan CT, Raymond AA, Wong CP, Wong SW, Omar H, Roslan H, Mohamed Z (2011) Association between ABCB1 polymorphism and response to sodium valproate treatment in Malaysian epilepsy patients. Epileptic Disord 13:65\u201375","journal-title":"Epileptic Disord"},{"key":"906_CR14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/17453670903025378","volume":"80","author":"W He","year":"2009","unstructured":"He W, Li K (2009) Incidence of genetic polymorphisms involved in lipid metabolism among Chinese patients with osteonecrosis of the femoral head. Acta Orthop 80:325\u2013329","journal-title":"Acta Orthop"},{"key":"906_CR15","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.bcp.2009.10.026","volume":"79","author":"SJ Hemauer","year":"2010","unstructured":"Hemauer SJ, Nanovskaya TN, Abdel-Rahman SZ, Patrikeeva SL, Hankins GD, Ahmed MS (2010) Modulation of human placental P-glycoprotein expression and activity by MDR1 gene polymorphisms. Biochem Pharmacol 79:921\u2013925","journal-title":"Biochem Pharmacol"},{"key":"906_CR16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.placenta.2010.02.010","volume":"31","author":"JR Hutson","year":"2010","unstructured":"Hutson JR, Koren G, Matthews SG (2010) Placental P-glycoprotein and breast cancer resistance protein: influence of polymorphisms on fetal drug exposure and physiology. Placenta 31:351\u2013357","journal-title":"Placenta"},{"key":"906_CR17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.placenta.2012.01.008","volume":"33","author":"M Iqbal","year":"2012","unstructured":"Iqbal M, Audette MC, Petropoulos S, Gibb W, Matthews SG (2012) Placental drug transporters and their role in fetal protection. Placenta 33:137\u2013142","journal-title":"Placenta"},{"key":"906_CR18","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1161\/CIRCULATIONAHA.106.183216","volume":"115","author":"KJ Jenkins","year":"2007","unstructured":"Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels SR, Elixson M, Warnes CA, Webb CL (2007) Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115:2995\u20133014","journal-title":"Circulation"},{"key":"906_CR19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yebeh.2007.04.013","volume":"11","author":"P Kwan","year":"2007","unstructured":"Kwan P, Baum L, Wong V, Ng PW, Lui CH, Sin NC, Hui AC, Yu E, Wong LK (2007) Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese. Epilepsy Behav 11:112\u2013117","journal-title":"Epilepsy Behav"},{"key":"906_CR20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0890-6238(98)00027-6","volume":"12","author":"GR Lankas","year":"1998","unstructured":"Lankas GR, Wise LD, Cartwright ME, Pippert T, Umbenhauer DR (1998) Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod Toxicol 12:457\u2013463","journal-title":"Reprod Toxicol"},{"key":"906_CR21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cca.2007.05.008","volume":"383","author":"D Li","year":"2007","unstructured":"Li D, Zhu JY, Gao J, Wang X, Lou YQ, Zhang GL (2007) Polymorphisms of tumor necrosis factor-alpha, interleukin-10, cytochrome P450 3A5, and ABCB1 in Chinese liver transplant patients treated with immunosuppressant tacrolimus. Clin Chim Acta 383:133\u2013139","journal-title":"Clin Chim Acta"},{"key":"906_CR22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2458-11-35","volume":"11","author":"Y Liu","year":"2011","unstructured":"Liu Y, Tong G, Tong W, Lu L, Qin X (2011) Can body mass index, waist circumference, waist\u2013hip ratio, and waist\u2013height ratio predict the presence of multiple metabolic risk factors in Chinese subjects? BMC Public Health 11:35","journal-title":"BMC Public Health"},{"key":"906_CR23","first-page":"337","volume":"41","author":"XQ Liu","year":"2013","unstructured":"Liu XQ, Mai JZ, Gao XM, Wu Y, Nie ZQ, Ou YQ, Chen JM, Zhuang J (2013) Current prevalence rate of congenital heart disease in 12-month-old and younger infants among four regions of Guangdong province. Zhonghua Xin Xue Guan Bing Za Zhi 41:337\u2013340","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"906_CR24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clpt.2003.09.012","volume":"75","author":"C Marzolini","year":"2004","unstructured":"Marzolini C, Paus E, Buclin T, Kim RB (2004) Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther 75:13\u201333","journal-title":"Clin Pharmacol Ther"},{"key":"906_CR25","doi-asserted-by":"crossref","first-page":"R963","DOI":"10.1152\/ajpregu.00173.2005","volume":"289","author":"AA Mathias","year":"2005","unstructured":"Mathias AA, Hitti J, Unadkat JD (2005) P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am J Physiol Regul Integr Comp Physiol 289:R963\u2013R969","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"906_CR26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yebeh.2011.02.015","volume":"21","author":"H Meng","year":"2011","unstructured":"Meng H, Guo G, Ren J, Zhou H, Ge Y, Guo Y (2011) Effects of ABCB1 polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy. Epilepsy Behav 21:27\u201330","journal-title":"Epilepsy Behav"},{"key":"906_CR27","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/aps.2012.136","volume":"33","author":"XG Meng","year":"2012","unstructured":"Meng XG, Guo CX, Feng GQ, Zhao YC, Zhou BT, Han JL, Chen X, Shi Y, Shi HY, Yin JY, Peng XD, Pei Q, Zhang W, Wang G, He M, Liu M, Yang JK, Zhou HH (2012) Association of CYP3A polymorphisms with the pharmacokinetics of cyclosporine A in early post-renal transplant recipients in China. Acta Pharmacol Sin 33:1563\u20131570","journal-title":"Acta Pharmacol Sin"},{"key":"906_CR28","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0006-2952(03)00178-3","volume":"65","author":"N Morita","year":"2003","unstructured":"Morita N, Yasumori T, Nakayama K (2003) Human MDR1 polymorphism: G2677T\/A and C3435T have no effect on MDR1 transport activities. Biochem Pharmacol 65:1843\u20131852","journal-title":"Biochem Pharmacol"},{"key":"906_CR29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.placenta.2004.09.006","volume":"26","author":"P Myllynen","year":"2005","unstructured":"Myllynen P, Pasanen M, Pelkonen O (2005) Human placenta: a human organ for developmental toxicology research and biomonitoring. Placenta 26:361\u2013371","journal-title":"Placenta"},{"key":"906_CR30","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1517\/17425250903304049","volume":"5","author":"P Myllynen","year":"2009","unstructured":"Myllynen P, Immonen E, Kummu M, Vahakangas K (2009) Developmental expression of drug-metabolizing enzymes and transporter proteins in human placenta and fetal tissues. Expert Opin Drug Metab Toxicol 5:1483\u20131499","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"906_CR31","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.tiv.2007.05.011","volume":"21","author":"M Myren","year":"2007","unstructured":"Myren M, Mose T, Mathiesen L, Knudsen LE (2007) The human placenta: an alternative for studying foetal exposure. Toxicol In Vitro 21:1332\u20131340","journal-title":"Toxicol In Vitro"},{"key":"906_CR32","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2174\/138920111795164057","volume":"12","author":"Z Ni","year":"2011","unstructured":"Ni Z, Mao Q (2011) ATP-binding cassette efflux transporters in human placenta. Curr Pharm Biotechnol 12:674\u2013685","journal-title":"Curr Pharm Biotechnol"},{"key":"906_CR33","first-page":"236","volume":"204","author":"SA Obermann-Borst","year":"2011","unstructured":"Obermann-Borst SA, Isaacs A, Younes Z, van Schaik RH, van der Heiden IP, van Duyn CM, Steegers EA, Steegers-Theunissen RP (2011) General maternal medication use, folic acid, the MDR1 C3435T polymorphism, and the risk of a child with a congenital heart defect. Am J Obstet Gynecol 204:236","journal-title":"Am J Obstet Gynecol"},{"key":"906_CR34","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1124\/dmd.110.033571","volume":"38","author":"C Prouillac","year":"2010","unstructured":"Prouillac C, Lecoeur S (2010) The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies. Drug Metab Dispos 38:1623\u20131635","journal-title":"Drug Metab Dispos"},{"key":"906_CR35","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S1734-1140(11)70594-1","volume":"63","author":"F Qiu","year":"2011","unstructured":"Qiu F, He XJ, Sun YX, Li-Ling J, Zhao LM (2011) Influence of ABCB1, CYP3A4*18B, and CYP3A5*3 polymorphisms on cyclosporine A pharmacokinetics in bone marrow transplant recipients. Pharmacol Rep 63:815\u2013825","journal-title":"Pharmacol Rep"},{"key":"906_CR36","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1755-5949.2012.00336.x","volume":"18","author":"J Qu","year":"2012","unstructured":"Qu J, Zhou BT, Yin JY, Xu XJ, Zhao YC, Lei GH, Tang Q, Zhou HH, Liu ZQ (2012) ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients. CNS Neurosci Ther 18:647\u2013651","journal-title":"CNS Neurosci Ther"},{"key":"906_CR37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0960327108088971","volume":"27","author":"M Rahi","year":"2008","unstructured":"Rahi M, Heikkinen T, Hakkola J, Hakala K, Wallerman O, Wadelius M, Wadelius C, Laine K (2008) Influence of adenosine triphosphate and ABCB1 (MDR1) genotype on the P-glycoprotein-dependent transfer of saquinavir in the dually perfused human placenta. Hum Exp Toxicol 27:65\u201371","journal-title":"Hum Exp Toxicol"},{"key":"906_CR38","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S1734-1140(12)70954-4","volume":"64","author":"B Rubis","year":"2012","unstructured":"Rubis B, Holysz H, Barczak W, Gryczka R, Lacinski M, Jagielski P, Czernikiewicz A, Polrolniczak A, Wojewoda A, Perz K, Bialek P, Morze K, Kandula Z, Lisiak N, Mrozikiewicz PM, Grodecka-Gazdecka S, Rybczynska M (2012) Study of ABCB1 polymorphism frequency in breast cancer patients from Poland. Pharmacol Rep 64:1560\u20131566","journal-title":"Pharmacol Rep"},{"key":"906_CR39","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijoa.2010.03.001","volume":"19","author":"AT Sia","year":"2010","unstructured":"Sia AT, Sng BL, Lim EC, Law H, Tan EC (2010) The influence of ATP-binding cassette sub-family B member-1 (ABCB1) genetic polymorphisms on acute and chronic pain after intrathecal morphine for caesarean section: a prospective cohort study. Int J Obstet Anesth 19:254\u2013260","journal-title":"Int J Obstet Anesth"},{"key":"906_CR40","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI7963","volume":"104","author":"JW Smit","year":"1999","unstructured":"Smit JW, Huisman MT, van Tellingen O, Wiltshire HR, Schinkel AH (1999) Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Invest 104:1441\u20131447","journal-title":"J Clin Invest"},{"key":"906_CR41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-60761-416-6_10","volume":"596","author":"F Staud","year":"2010","unstructured":"Staud F, Ceckova M, Micuda S, Pavek P (2010) Expression and function of P-glycoprotein in normal tissues: effect on pharmacokinetics. Methods Mol Biol 596:199\u2013222","journal-title":"Methods Mol Biol"},{"key":"906_CR42","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/1061186X.2012.716847","volume":"20","author":"F Staud","year":"2012","unstructured":"Staud F, Cerveny L, Ceckova M (2012) Pharmacotherapy in pregnancy: effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure. J Drug Target 20:736\u2013763","journal-title":"J Drug Target"},{"key":"906_CR43","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.placenta.2005.05.007","volume":"27","author":"M Sun","year":"2006","unstructured":"Sun M, Kingdom J, Baczyk D, Lye SJ, Matthews SG, Gibb W (2006) Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta 27:602\u2013609","journal-title":"Placenta"},{"key":"906_CR44","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1476-5381.2009.00336.x","volume":"158","author":"K Vahakangas","year":"2009","unstructured":"Vahakangas K, Myllynen P (2009) Drug transporters in the human blood\u2013placental barrier. Br J Pharmacol 158:665\u2013678","journal-title":"Br J Pharmacol"},{"key":"906_CR45","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/eurheartj\/ehn170","volume":"29","author":"LM Driel van","year":"2008","unstructured":"van Driel LM, Smedts HP, Helbing WA, Isaacs A, Lindemans J, Uitterlinden AG, van Duijn CM, de Vries JH, Steegers EA, Steegers-Theunissen RP (2008) Eightfold increased risk for congenital heart defects in children carrying the nicotinamide N-methyltransferase polymorphism and exposed to medicines and low nicotinamide. Eur Heart J 29:1424\u20131431","journal-title":"Eur Heart J"},{"key":"906_CR46","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/annhyg\/46.5.465","volume":"46","author":"M Tongeren Van","year":"2002","unstructured":"Van Tongeren M, Nieuwenhuijsen MJ, Gardiner K, Armstrong B, Vrijheid M, Dolk H, Botting B (2002) A job-exposure matrix for potential endocrine-disrupting chemicals developed for a study into the association between maternal occupational exposure and hypospadias. Ann Occup Hyg 46:465\u2013477","journal-title":"Ann Occup Hyg"},{"key":"906_CR47","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/FPC.0b013e328165249f","volume":"17","author":"H Wang","year":"2007","unstructured":"Wang H, Ding K, Zhang Y, Jin L, Kullo IJ, He F (2007) Comparative and evolutionary pharmacogenetics of ABCB1: complex signatures of positive selection on coding and regulatory regions. Pharmacogenet Genomics 17:667\u2013678","journal-title":"Pharmacogenet Genomics"},{"key":"906_CR48","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/138920008783571828","volume":"9","author":"N Weier","year":"2008","unstructured":"Weier N, He SM, Li XT, Wang LL, Zhou SF (2008) Placental drug disposition and its clinical implications. Curr Drug Metab 9:106\u2013121","journal-title":"Curr Drug Metab"},{"key":"906_CR49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1423-0127-17-16","volume":"17","author":"G Wu","year":"2010","unstructured":"Wu G, Nan C, Rollo JC, Huang X, Tian J (2010) Sodium valproate-induced congenital cardiac abnormalities in mice are associated with the inhibition of histone deacetylase. J Biomed Sci 17:16","journal-title":"J Biomed Sci"},{"key":"906_CR50","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00432-012-1209-z","volume":"138","author":"H Wu","year":"2012","unstructured":"Wu H, Kang H, Liu Y, Tong W, Liu D, Yang X, Lian M, Yao W, Zhao H, Huang D, Sha X, Wang E, Wei M (2012) Roles of ABCB1 gene polymorphisms and haplotype in susceptibility to breast carcinoma risk and clinical outcomes. J Cancer Res Clin Oncol 138:1449\u20131462","journal-title":"J Cancer Res Clin Oncol"},{"key":"906_CR51","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.7314\/APJCP.2013.14.5.3085","volume":"14","author":"AM Yue","year":"2013","unstructured":"Yue AM, Xie ZB, Zhao HF, Guo SP, Shen YH, Wang HP (2013) Associations of ABCB1 and XPC genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis in a Chinese population. Asian Pac J Cancer Prev 14:3085\u20133091","journal-title":"Asian Pac J Cancer Prev"},{"key":"906_CR52","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/CIRCULATIONAHA.111.050245","volume":"125","author":"JY Zhao","year":"2012","unstructured":"Zhao JY, Yang XY, Gong XH, Gu ZY, Duan WY, Wang J, Ye ZZ, Shen HB, Shi KH, Hou J, Huang GY, Jin L, Qiao B, Wang HY (2012) Functional variant in methionine synthase reductase intron-1 significantly increases the risk of congenital heart disease in the Han Chinese population. Circulation 125:482\u2013490","journal-title":"Circulation"},{"key":"906_CR53","first-page":"5","volume":"23","author":"B Zhou","year":"2002","unstructured":"Zhou B (2002) Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Zhonghua Liu Xing Bing Xue Za Zhi 23:5\u201310","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"906_CR54","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/00498250701867889","volume":"38","author":"SF Zhou","year":"2008","unstructured":"Zhou SF (2008) Structure, function, and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 38:802\u2013832","journal-title":"Xenobiotica"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-014-0906-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-014-0906-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-014-0906-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T22:44:33Z","timestamp":1597704273000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-014-0906-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,17]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["906"],"URL":"https:\/\/doi.org\/10.1007\/s00246-014-0906-6","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,17]]}}}